What is the management approach for a newborn or adult with hypoxic ischemic encephalopathy (HIE) following a significant hypoxic event?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypoxic-Ischemic Encephalopathy

Therapeutic hypothermia (cooling to 33-34°C for 72 hours) is the only proven treatment for moderate-to-severe HIE in term and near-term infants (≥36 weeks gestational age), and must be initiated within 6 hours of birth to reduce death or major neurodevelopmental disability. 1, 2

Patient Selection Criteria

Therapeutic hypothermia should be offered to infants who meet ALL of the following criteria: 2

  • Gestational age ≥36 weeks (some protocols specify ≥37 weeks) 1, 2
  • Evidence of perinatal asphyxia (documented hypoxic event) 2
  • Moderate-to-severe encephalopathy on clinical examination 1
  • Age <6 hours from birth at time of treatment initiation 1, 2

Cooling Protocol Requirements

The protocol must follow strict parameters established in randomized trials: 1, 2

  • Initiate within 6 hours of birth - efficacy decreases significantly after this window 1, 2
  • Target core temperature: 33-34°C (33.5-34.5°C) 1
  • Duration: 72 hours of continuous cooling 1, 2
  • Rewarming: Over at least 4 hours at approximately 0.5°C per hour 1, 2
  • Both whole-body cooling and selective head cooling are acceptable methods 1

Expected Outcomes

The magnitude of benefit is substantial and varies by severity: 2, 3

  • Overall: 22-33% reduction in death or major neurodevelopmental disability 2, 3
  • Number needed to treat: 5-7 infants to prevent one case of death or significant disability 2, 3
  • Moderate HIE: 33% risk reduction (RR 0.67; 95% CI 0.56-0.81) 3
  • Severe HIE: 17% risk reduction (RR 0.83; 95% CI 0.74-0.92) 3
  • Cerebral palsy: 48% reduction (RR 0.52; 95% CI 0.37-0.72) 2, 3
  • Blindness: 52% reduction (RR 0.48; 95% CI 0.22-1.03) 2, 3
  • Deafness: 58% reduction (RR 0.42; 95% CI 0.21-0.82) 2, 3

Facility Requirements

Cooling should ONLY be performed in facilities with comprehensive neonatal intensive care capabilities: 1, 2, 3

  • Intravenous therapy and volume expansion capability 2, 3
  • Respiratory support and mechanical ventilation 2, 3
  • Continuous pulse oximetry and cardiorespiratory monitoring 2, 3
  • Antibiotics and anticonvulsant medications 2, 3
  • Blood transfusion services 2, 3
  • Radiology including ultrasound and ideally MRI 2, 3
  • Pathology testing for metabolic workup 2, 3
  • Multidisciplinary care team with longitudinal follow-up 1, 2

Supportive Care During Cooling

Immediate Resuscitation

If the infant requires resuscitation at birth: 1

  • Establish adequate ventilation first - bradycardia in newborns is usually from inadequate lung inflation or hypoxemia 1
  • Use room air initially for term infants rather than 100% oxygen 1
  • Epinephrine (if heart rate <60 despite adequate ventilation and compressions): IV route preferred at 0.01-0.03 mg/kg of 1:10,000 concentration 1
  • Volume expansion: 10 mL/kg isotonic crystalloid or blood if blood loss suspected 1
  • Avoid rapid volume infusions in premature infants due to intraventricular hemorrhage risk 1

Metabolic Management

Glucose monitoring and correction are critical: 1

  • Avoid hypoglycemia - lower glucose levels increase risk of brain injury after hypoxic-ischemic insult 1
  • Start IV glucose infusion as soon as practical after resuscitation 1
  • No specific target glucose range has been identified, but hypoglycemia must be prevented 1

Physiological Stability During Cooling

Maintain the following parameters: 2

  • Adequate ventilation and oxygenation 2
  • Target PaCO₂: 4.5-5.0 kPa 2
  • Systolic blood pressure >110 mmHg 2
  • Monitor for complications: thrombocytopenia and hypotension are known adverse effects of cooling 1

Seizure Management

Seizures occur in 46-65% of HIE cases, with 90% occurring within the first 2 days: 4

  • Correct metabolic derangements BEFORE anticonvulsants: hypocalcemia, hypomagnesemia, and hypoglycemia 4
  • Continuous video-EEG monitoring is essential - many seizures are subclinical 4
  • Do not use naloxone as part of initial resuscitation for respiratory depression 1

Diagnostic Workup

Neuroimaging Algorithm

Based on clinical stability: 4

  • Head ultrasound: Initial bedside imaging if infant unstable or MRI unavailable - identifies hemorrhage, hydrocephalus, white matter changes 4
  • MRI with diffusion-weighted imaging: Gold standard for HIE, most sensitive for hypoxic-ischemic injury 4
  • CT head: Limited role, specific for hemorrhagic lesions with birth trauma history 4

Laboratory Evaluation

Essential immediate testing: 4

  • Electrolytes (sodium, calcium, magnesium) 4
  • Blood gas analysis 4
  • Complete blood count 4
  • Blood culture if infection suspected 4
  • Point-of-care glucose testing (mandatory) 4

Critical Pitfalls to Avoid

Do not initiate cooling beyond 6 hours of life - efficacy decreases significantly after this window 2

Do not rewarm rapidly - rewarming must occur over at least 4 hours to prevent complications 1, 2

Do not perform cooling without proper protocols and monitoring - risk of extreme hypothermia and other complications 3

Do not delay metabolic correction - hypoglycemia, hypocalcemia, and hypomagnesemia must be addressed immediately 4

Do not perform lumbar puncture in comatose infants - risk of herniation 4

Resource-Limited Settings

Therapeutic hypothermia is ONLY recommended when suitable supportive care is available - the World Health Organization gives this a weak recommendation with low-certainty evidence due to the absolute requirement for comprehensive monitoring and support capabilities 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Therapeutic Hypothermia in Hypoxic-Ischemic Encephalopathy (HIE)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Therapeutic Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Convulsions and Neonatal Convulsions: Diagnostic Approach and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.